Humana Inc.
HUM · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.63 | -0.24 | -0.02 | 0.05 |
| FCF Yield | 2.67% | 3.93% | 0.74% | -2.23% |
| EV / EBITDA | 100.18 | 34.28 | 19.80 | -87.44 |
| Quality | ||||
| ROIC | 1.96% | 3.36% | 7.52% | -3.75% |
| Gross Margin | -197.56% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 5.01 | 2.34 | 0.27 | 0.77 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.28% | 7.63% | 7.93% | 8.24% |
| Free Cash Flow Growth | -27.74% | 390.25% | 134.60% | -139.47% |
| Safety | ||||
| Net Debt / EBITDA | 18.75 | 7.71 | 4.38 | -20.74 |
| Interest Coverage | 2.38 | 4.72 | 10.57 | -5.26 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 7.40 | 12.52 | 12.50 | 8.33 |